Short Interest in NextPlat Corp (NASDAQ:NXPL) Grows By 1,762.1%

NextPlat Corp (NASDAQ:NXPL) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 54,000 shares, an increase of 1,762.1% from the November 30th total of 2,900 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average trading volume of 119,400 shares, the short-interest ratio is currently 0.5 days.

NextPlat Trading Down 1.7 %

Shares of NASDAQ NXPL traded down $0.02 during trading hours on Friday, hitting $1.16. The company’s stock had a trading volume of 136,139 shares, compared to its average volume of 277,463. NextPlat has a 12 month low of $0.71 and a 12 month high of $2.68. The stock has a market cap of $30.12 million, a price-to-earnings ratio of -1.71 and a beta of 0.85. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.04 and a current ratio of 3.70. The business has a 50-day simple moving average of $1.03 and a 200-day simple moving average of $1.13.

Institutional Investors Weigh In On NextPlat

An institutional investor recently bought a new position in NextPlat stock. Omnia Family Wealth LLC bought a new stake in shares of NextPlat Corp (NASDAQ:NXPL) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 93,429 shares of the company’s stock, valued at approximately $132,000. Omnia Family Wealth LLC owned approximately 0.49% of NextPlat at the end of the most recent quarter. Institutional investors and hedge funds own 1.30% of the company’s stock.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.